Non small cell lung cancer ultrasound

Non Small Cell Lung Cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Non Small Cell Lung Cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-Ray
CT Scan
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Management Approach Stage I Stage II Stage III Stage IV Metastatic Cancer
Medical Therapy Chemotherapy Radiation Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Non small cell lung cancer ultrasound On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Non small cell lung cancer ultrasound All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Non small cell lung cancer ultrasound
CDC on Non small cell lung cancer ultrasound
Non small cell lung cancer ultrasound in the news
Blogs on Non small cell lung cancer ultrasound
Directions to Hospitals Treating Non small cell carcinoma of the lung
Risk calculators and risk factors for Non small cell lung cancer ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

On endobronchial ultrasound (EBUS) and endoscopic ultrasound, characteristic findings of non-small cell lung cancer include enlarged lymph nodes and local invasion to adjacent bronchial structures and mediastinum. Endobronchial ultrasound is a first-line diagnostic modality for mediastinal staging.

Ultrasound

Endobronchial ultrasound is a first-line diagnostic modality for mediastinal staging.

• Endobronchial and endoscopic esophageal ultrasound are mainly used to identify mediastinal metastasis.
• On ultrasound (endobronchial/endoscopic esophageal ultrasound), characteristic findings of non-small cell lung cancer include:
  • Enlarged lymph nodes
  • Local invasion of adjacent bronchial structures and mediastinum
• Indications for the endobronchial ultrasound:
  • Evaluation of lymph nodes and other structures in the mediastinum
  • Mediastinal invasion staging
  • Plan for management
  • Real-time evaluation of structures

The table below summarizes the advantages and disadvantages of both ultrasound modalities, for the diagnostic assessment of non-small cell lung cancer.

Procedure	Advantages	Disadvantages
Endobronchial ultrasound (EBUS)	Direct visualization of lymph node stations. Complements endoscopic ultrasound: covers lymph node stations 2R and 4R which are difficult to access by endoscopic ultrasound Lower false-negative rate than with blind transbronchial fine needle aspiration and fewer complications	More invasive than endoscopic ultrasound, few practitioners, but rapidly growing in popularity
Endoscopic ultrasound (EUS)	Least invasive modality Uses the esophagus to access mediastinal lymph nodes Excellent for staging lymph node metastases Useful for station 2L and 4L, L adrenal, celiac lymph node	Cannot reliably access right sided paratracheal lymph node stations 2 R and 4R Accurate discrimination of primary hilar tumors and involved lymph nodes is important

References

Template:WikiDoc Sources